scholarly journals A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers

2014 ◽  
Vol 4 ◽  
pp. 717-724 ◽  
Author(s):  
Ke-Jun Liu ◽  
Zhong-Zhen Guan ◽  
Ying Liang ◽  
Xu-Qing Yang ◽  
Jin Peng ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Double Blind ◽  
Lung Cancers ◽  
First Line Therapy ◽  
Line Therapy ◽  
Randomized Phase Ii

Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer

2006 ◽  
Vol 61 (2) ◽  
pp. 143
Author(s):  
Ki Eun Hwang ◽  
So Young Kim ◽  
Jong Hoon Jung ◽  
Seong Hoon Park ◽  
Jung Hyun Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document